MedPath

Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive functio

Not Applicable
Conditions
schizophrenia
Registration Number
JPRN-UMIN000002076
Lead Sponsor
Kyoto University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

patients using epinephrine patients with allergic reaction to aripiprazole before diabetic patients and patients who have history of suffering from diabetes patients with (or, with the possibility of) pregnancy patients taking other antipsychotics other patients not suitable for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
apply neuropsychological tasks and evaluate the difference of the score
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath